Inder Kaul

Inder Kaul, MD, MPH, is an accomplished medical professional with extensive experience in clinical development and leadership roles in the pharmaceutical industry. Currently serving as Senior Vice President of Clinical Development at Bristol Myers Squibb and Karuna Therapeutics, Inder has previously held the position of President at both Kaul Consulting LLC and Asahi Kasei Pharma America Corporation, as well as Vice President of Clinical Development, Medical & Regulatory Affairs at Oscient Pharmaceuticals. Inder Kaul holds a Doctor of Medicine degree in Anesthesiology from the University of Kashmir and a Master of Public Health in Epidemiology & Biostatistics from Harvard University, which further enhances expertise in the development and regulation of medical advancements.